Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02183883
Title Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity (DARWIN1)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications

lung non-small cell carcinoma

Therapies

Afatinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.